Cost drivers for Medically Assisted Treatment in HIV control in Nairobi, Kenya

Simple item page
dc.contributor.authorWangusi, Rebeccah Namalea
dc.date.accessioned2023-02-21T09:51:52Z
dc.date.available2023-02-21T09:51:52Z
dc.date.issued2022
dc.descriptionA Dissertation submitted in partial fulfillment of the requirements for the award of the Degree of Master of Business Administration in Healthcare Management at Strathmore Universityen_US
dc.description.abstractAn estimated 18% of people who inject drugs in Kenya are infected with HIV. Medically Assisted Treatment with methadone offers promise as a HIV prevention strategy among this population. The costs of Medically Assisted Treatment services in two Kenyan public facilities were studied from an economic health care provider perspective. The objectives included: to determine the startup costs of setting up a medically assisted treatment clinic; to determine the annual recurrent costs and; to determine the annual unit cost per patient. The study utilized the cost of production theory. Data was collected from Ngara MAT Clinic and Mathari Teaching & Referral Hospital. Data were collected at the facility level using a micro-costing approach utilizing a modified version of the Drug Abuse Treatment Cost Analysis Program tool. Results showed that the total start-up costs ranged between $213,471.64 and $533,412.99 across the two sites with the cost of setting up a subsequent clinic being 50% less. An additional $316,294.77 and $ 365,080.32 were determined as the total annual recurrent costs necessary to run the program within the existing infrastructure for the different clinics. The annual per-patient cost of providing Medically Assisted Treatment ranged from $ 532 to $590 across the 2 sites, with an average cost of $562. This was lower than costs reported in upper and middle-income countries. Consistent with other studies, the main cost driver for Medically Assisted Treatment was personnel costs accounting for 59% of the total costs. For policymakers, the results of this study offer an opportunity to revisit and strengthen policies on Drug abuse prevention and financing for HIV prevention programs and Medically Assisted Treatment in particular.en_US
dc.identifier.urihttp://hdl.handle.net/11071/13128
dc.language.isoenen_US
dc.publisherStrathmore Universityen_US
dc.subjectMedically Assisted Treatmenten_US
dc.subjectMethadoneen_US
dc.subjectSub-Saharan Africaen_US
dc.subjectHIV Control_Kenyaen_US
dc.subjectCosten_US
dc.titleCost drivers for Medically Assisted Treatment in HIV control in Nairobi, Kenyaen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cost drivers for Medically Assisted Treatment in HIV control in Nairobi, Kenya.pdf
Size:
2.59 MB
Format:
Adobe Portable Document Format
Description:
Full - text thesis
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
MBA-HCM Theses and Dissertations (2022)